US House veterans committee holds hearing on psychedelic therapies for military veterans
Congress Holds Hearing On Psychedelics’ Medical Benefits For Military Veterans
A US House Veterans' Affairs health subcommittee held a Wednesday hearing on veterans' access to psychedelic-assisted therapies, with VA officials and researchers testifying. The VA's Andrew Gradison said the department is running 21 active clinical studies on psychedelics, including an August-announced psilocybin trial in veterans with treatment-resistant depressiontreatment-resistant depressionDepression that has not improved enough after adequate courses of at least two antidepressant treatments.Open the glossary.
Key facts
- Kind of item
- Guidance and consultations
- Compounds
- Psilocybin, MDMA, Ibogaine
- Condition
- PTSD
- Regulator
- FDA (United States)
- Jurisdiction
- United States
- Source
- Marijuana Moment (psychedelics policy only) (marijuanamoment.net)
- Published
- Original
- Read it at marijuanamoment.net
How this summary was made
The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method
Source: Marijuana Moment (psychedelics policy only) · marijuanamoment.net
Connected to
- Kind of item
- Guidance and consultations
- Compounds
- PsilocybinMDMAIbogaine
- Condition
- PTSD
- Regulator
- FDA (United States)
- Jurisdiction
- United States